A Zic2/Runx2/NOLC1 signaling axis mediates tumor growth and metastasis in clear cell renal cell carcinoma
Open Access
- 25 March 2021
- journal article
- research article
- Published by Springer Nature in Cell Death & Disease
- Vol. 12 (4) , 1-11
Abstract
Clear cell renal cell carcinoma (ccRCC) is one of the most common malignancies with rapid growth and high metastasis, but lacks effective therapeutic targets. Here, using public sequencing data analyses, quantitative real-time PCR assay, western blotting, and IHC staining, we characterized that runt-related transcription factor 2 (Runx2) was significantly upregulated in ccRCC tissues than that in normal renal tissues, which was associated with the worse survival of ccRCC patients. Overexpression of Runx2 promoted malignant proliferation and migration of ccRCC cells, and inversely, interfering Runx2 with siRNA attenuates its oncogenic ability. RNA sequencing and functional studies revealed that Runx2 enhanced ccRCC cell growth and metastasis via downregulation of tumor suppressor nucleolar and coiled-body phosphoprotein 1 (NOLC1). Moreover, increased Zic family member 2 (Zic2) was responsible for the upregulation of Runx2 and its oncogenic functions in ccRCC. Kaplan–Meier survival analyses indicated that ccRCC patients with high Zic2/Runx2 and low NOLC1 had the worst outcome. Therefore, our study demonstrates that Zic2/Runx2/NOLC1 signaling axis promotes ccRCC progression, providing a set of potential targets and prognostic indicators for patients with ccRCC.Keywords
Funding Information
- National Natural Science Foundation of China (81472380 and 81872085)
This publication has 45 references indexed in Scilit:
- Inhibition of RUNX2 Transcriptional Activity Blocks the Proliferation, Migration and Invasion of Epithelial Ovarian Carcinoma CellsPLOS ONE, 2013
- Runt-related transcription factor 2 (RUNX2) inhibits p53-dependent apoptosis through the collaboration with HDAC6 in response to DNA damageCell Death & Disease, 2013
- Clinical significance of RUNX2 expression in patients with nonsmall cell lung cancer: a 5-year follow-up studyTumor Biology, 2013
- The cancer‐related transcription factor Runx2 modulates cell proliferation in human osteosarcoma cell linesJournal of Cellular Physiology, 2012
- Transcriptional repression of RUNX2 is associated with aggressive clinicopathological outcomes, whereas nuclear location of the protein is related to metastasis in prostate cancerProstate Cancer and Prostatic Diseases, 2012
- Transcription factor Runx2 is a regulator of epithelial–mesenchymal transition and invasion in thyroid carcinomasLaboratory Investigation, 2012
- A systematic RNAi synthetic interaction screen reveals a link between p53 and snoRNP assemblyNature Cell Biology, 2011
- Identification of nucleolar and coiled-body phosphoprotein 1 (NOLC1) minimal promoter regulated by NF-κB and CREBBMB Reports, 2011
- Runx2 in normal tissues and cancer cells: A developing storyBlood Cells, Molecules, and Diseases, 2010
- NOLC1, an Enhancer of Nasopharyngeal Carcinoma Progression, Is Essential for TP53 to Regulate MDM2 ExpressionThe American Journal of Pathology, 2009